Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He Y, Franchi L, Nunez G. TLR agonists stimulate Nlrp3-dependent IL-1beta production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J Immunol. 2013;190:334–9.

Article  CAS  PubMed  Google Scholar 

Szekanecz Z, Szamosi S, Kovacs GE, Kocsis E, Benko S. The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout. Arch Biochem Biophys. 2019;670:82–93.

Article  CAS  PubMed  Google Scholar 

Mao L, Kitani A, Strober W, Fuss IJ. The role of NLRP3 and IL-1beta in the pathogenesis of inflammatory bowel disease. Front Immunol. 2018;9:2566.

Article  PubMed  PubMed Central  Google Scholar 

Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov. 2018;17:588–606.

Article  CAS  PubMed  Google Scholar 

Kinra M, Nampoothiri M, Arora D, Mudgal J. Reviewing the importance of TLR-NLRP3-pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors. Scand J Immunol. 2022;95:e13124.

Article  CAS  PubMed  Google Scholar 

Blevins HM, Xu Y, Biby S, Zhang S. The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases. Front Aging Neurosci. 2022;14:879021.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C, et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell. 2007;130:918–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hayden MS, Ghosh S. NF-kappaB in immunobiology. Cell Res. 2011;21:223–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su CC, Wang SC, Chen IC, Chiu FY, Liu PL, Huang CH, et al. Zerumbone suppresses the LPS-induced inflammatory response and represses activation of the NLRP3 inflammasome in macrophages. Front Pharmacol. 2021;12:652860.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuemmerle-Deschner JB, Hachulla E, Cartwright R, Hawkins PN, Tran TA, Bader-Meunier B, et al. Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes. Ann Rheum Dis. 2011;70:2095–102.

Article  CAS  PubMed  Google Scholar 

Dinarello CA, van der Meer JW. Treating inflammation by blocking interleukin-1 in humans. Semin Immunol. 2013;25:469–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Suzuki MT, Parrot D, Berg G, Grube M, Tomasi S. Lichens as natural sources of biotechnologically relevant bacteria. Appl Microbiol Biotechnol. 2016;100:583–95.

Article  CAS  PubMed  Google Scholar 

Mendili M, Khadhri A, Mediouni-Ben Jemaa J, Andolfi A, Tufano I, Aschi-Smiti S, et al. Anti-inflammatory potential of compounds isolated from tunisian lichens species. Chem Biodivers. 2022;19:e202200134.

Article  CAS  PubMed  Google Scholar 

Kumar KC, Muller K. Lichen metabolites. 1. Inhibitory action against leukotriene B4 biosynthesis by a non-redox mechanism. J Nat Prod. 1999;62:817–20.

Article  CAS  PubMed  Google Scholar 

Bugni TS, Andjelic CD, Pole AR, Rai P, Ireland CM, Barrows LR. Biologically active components of a Papua New Guinea analgesic and anti-inflammatory lichen preparation. Fitoterapia. 2009;80:270–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Melo MGD, Araujo AAD, Serafini MR, Carvalho LF, Bezerra MS, Ramos CS, et al. Anti-inflammatory and toxicity studies of atranorin extracted from Cladina kalbii Ahti in rodents. Braz J Pharm Sci. 2011;47:861–72.

Article  Google Scholar 

Shi H, Murray A, Beutler B. Reconstruction of the mouse inflammasome system in HEK293T cells. Bio Protoc. 2016;6:e1986.

Article  PubMed  Google Scholar 

Coll RC, Robertson AA, Chae JJ, Higgins SC, Munoz-Planillo R, Inserra MC, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21:248–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundback T, Nordlund P, et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc. 2014;9:2100–22.

Article  CAS  PubMed  Google Scholar 

Pai MY, Lomenick B, Hwang H, Schiestl R, McBride W, Loo JA, et al. Drug affinity responsive target stability (DARTS) for small-molecule target identification. Methods Mol Biol. 2015;1263:287–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhong Y, Kinio A, Saleh M. Functions of NOD-like receptors in human diseases. Front Immunol. 2013;4:333.

Article  PubMed  PubMed Central  Google Scholar 

Hoss F, Rodriguez-Alcazar JF, Latz E. Assembly and regulation of ASC specks. Cell Mol Life Sci. 2017;74:1211–29.

Article  CAS  PubMed  Google Scholar 

Martinez Molina D, Jafari R, Ignatushchenko M, Seki T, Larsson EA, Dan C, et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science. 2013;341:84–87.

Article  PubMed  Google Scholar 

Lomenick B, Hao R, Jonai N, Chin RM, Aghajan M, Warburton S, et al. Target identification using drug affinity responsive target stability (DARTS). Proc Natl Acad Sci USA. 2009;106:21984–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poyet JL, Srinivasula SM, Tnani M, Razmara M, Fernandes-Alnemri T, Alnemri ES. Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J Biol Chem. 2001;276:28309–13.

Article  CAS  PubMed  Google Scholar 

Okondo MC, Rao SD, Taabazuing CY, Chui AJ, Poplawski SE, Johnson DC, et al. Inhibition of Dpp8/9 activates the Nlrp1b inflammasome. Cell Chem Biol. 2018;25:262–7.e265.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pelegrin P, Barroso-Gutierrez C, Surprenant A. P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage. J Immunol. 2008;180:7147–57.

Article  CAS  PubMed  Google Scholar 

Lugrin J, Martinon F. The AIM2 inflammasome: sensor of pathogens and cellular perturbations. Immunol Rev. 2018;281:99–114.

Article  CAS  PubMed  Google Scholar 

Chen Y, He H, Lin B, Chen Y, Deng X, Jiang W, et al. RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor. Cell Mol Immunol. 2021;18:1425–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu G, Fu S, Zhan X, Wang Z, Zhang P, Shi W, et al. Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90. JCI Insight. 2021;6:e134601.

Article  PubMed  PubMed Central  Google Scholar 

Marchetti C, Swartzwelter B, Gamboni F, Neff CP, Richter K, Azam T, et al. OLT1177, a beta-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. Proc Natl Acad Sci USA. 2018;115:E1530–E1539.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu J, Luo Y, Jiang Q, Li S, Huang W, Xiang L, et al. Coptisine from Coptis chinensis blocks NLRP3 inflammasome activation by inhibiting caspase-1. Pharmacol Res. 2019;147:104348.

Article  CAS  PubMed  Google Scholar 

Xu X, Li J, Long X, Tao S, Yu X, Ruan X, et al. C646 protects against DSS-induced colitis model by targeting NLRP3 inflammasome. Front Pharmacol. 2021;12:707610.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237–41.

Article  CAS  PubMed  Google Scholar